(IN BRIEF) Researchers at the Karlsruhe Institute of Technology (KIT) have created a nanodroplet-based chip platform that combines drug synthesis, biological testing, and chemical analysis in a single workflow. Each droplet measures only 200 nanoliters and contains 300 cells, enabling … Read the full press release
Posted in Business, Education, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged Angewandte Chemie, biotechnology, cancer research, Carsten Hopf, CeMOS, colon cancer, direct-to-biology, drug discovery, HT-29, Karlsruhe Institute of Technology, KIT, Liana Bauer, MALDI-MSI, MEK inhibitors, miniaturized workflow, mirdametinib, nanodroplet array platform, Pavel Levkin, pharmaceuticals, skin cancer, TH Mannheim
(IN BRIEF) A doctoral study at the University of Helsinki shows that women with a history of pre-eclampsia face significantly higher risks of cardiovascular disease later in life, but hormone therapy used during menopause can help reduce this risk while … Read the full press release
Posted in Business, Education, Financial, Finland, Healthcare, Industrial, Investment, Management, Marketing, News, Technology
Tagged cardiovascular disease, doctoral thesis, Finland, hormone therapy, hypertensive pregnancy disorders, ischaemic heart disease, menopause, Minttu Venetkoski, Naistenklinikka, pre-eclampsia, stroke risk, University of Helsinki, Women’s Health
(IN BRIEF) The Institute of Cancer Research, London, has published two major studies demonstrating how pairing a cancer-killing reovirus with targeted therapies such as talazoparib and palbociclib can greatly strengthen immune activity and tumour destruction. By disrupting cancer cell defences … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged Cancer Research UK, immune activation, immune checkpoint inhibitors, Joan Kyula-Currie, Kevin Harrington, London, Nature Communications, oncolytic virus, Oncolytics Biotech, Palbociclib, PARP-1, personalised cancer therapies, reovirus, RIG-I, Royal Marsden, talazoparib, The Institute of Cancer Research, tumour stress response, Victoria Roulstone, virotherapy
(IN BRIEF) The University of Liverpool and Imperial College London, working with international partners, have published the first global systematic review of hepatitis B care, commissioned by WHO and covering over 1.7 million patients across 50 countries. The analysis found … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Non Profit, Science, Technology, United Kingdom
Tagged Alexander Stockdale, antiviral therapy, chronic hepatitis B, decentralised healthcare, diagnosis gaps, global elimination target 2030, global health, Hepatitis B, HIV care models, Imperial College London, maternal health, partnership, Patient Retention, Philippa Easterbrook, postpartum care, primary care, The Lancet Gastroenterology & Hepatology, treatment initiation, University of Liverpool, WHO, World Health Organization
(IN BRIEF) KUKA, in partnership with Austrian company intelligent motion, has introduced hirob, a rehabilitation robot designed to replicate the therapeutic benefits of hippotherapy without horses. Using a KR QUANTEC robot, the system mimics the precise walking motion of a … Read the full press release
Posted in Business, Electronics & Machinery, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology
Tagged Dr. Andreas Mayr, hirob, intelligent motion, KR QUANTEC robot, KUKA, Landeskrankenhaus Hochzirl, Lara Leutgeb, multiple sclerosis therapy, musculoskeletal rehabilitation, neurological rehabilitation, neuroplasticity, parttnership, pelvic floor therapy, rehabilitation robotics, robotic hippotherapy, stroke recovery, therapeutic riding technology, traumatic brain injury therapy
(IN BRIEF) Boehringer Ingelheim has entered into a global collaboration and licensing agreement with Palatin Technologies to develop melanocortin receptor agonists as a new treatment for retinal diseases, beginning with diabetic retinopathy and diabetic macular edema. The approach targets inflammation, … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged biopharmaceutical collaboration, Boehringer Ingelheim, Carl Spana, diabetic macular edema, diabetic retinopathy, eye health innovation, inflammation, licensing agreement, melanocortin receptor agonists, neurodegeneration, Palatin Technologies, parttnership, Remko Bakker, Retinal Disease Treatment, vascular dysfunction, Vision Preservation, €280 million milestone payments
(IN BRIEF) The University of Glasgow, working in partnership with Dogs Trust, is calling on owners of two or more puppies from the same litter to join the Generation Pup study, a large-scale project aimed at understanding how early life … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged canine stress resilience, Chih Hsin Kuo, dog health, dog welfare research, Dogs Trust, early life experiences in dogs, Generation Pup, Glasgow rehoming centre, Jane Murray, littermate study, multi-dog households, parttnership, puppy behaviour, UK dog welfare, University of Glasgow, West Calder rehoming centre
(IN BRIEF) Novartis will present 19 abstracts at the 2025 European Society of Cardiology (ESC) Congress in Madrid, showcasing new findings across its cardiovascular portfolio. Key highlights include two VictORION studies on Leqvio’s impact on quality of life and its … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged abelacimab, atrial fibrillation, AZALEA-TIMI 71, cardiovascular disease, cardiovascular pipeline therapies, Chagas disease, Entresto, ESC Congress 2025, European Society of Cardiology, heart failure, inclisiran, Leqvio, lipoprotein apheresis, lipoprotein(a), Lp(a)FRONTIERS APHERESIS trial, Novartis, PARACHUTE-HF trial, pelacarsen, Sacubitril Valsartan, VictORION studies, xRNA platform
(IN BRIEF) A University of Exeter pilot study has found that a self-guided, four-week nature-based programme called Roots and Shoots can significantly improve wellbeing and reduce symptoms of depression and anxiety. Tested with 47 adults, the programme led to measurable … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged anxiety, Behavioral Sciences, depression, Hannah Bunce, Matt Owens, mental health, mindfulness, nature connection, nature-based self-help, pilot study, Roots and Shoots, ROWAN, self-guided programme, UK mental health, University of Exeter, wellbeing
(IN BRIEF) Professor Chrissie Thirlwell, Head of the University of Bristol Medical School and Medical Oncologist, will compete in the Bosphorus Cross-Continental Swim on 24 August, marking the final leg of her 20-year “crossing continents” swimming series. The 6.5km race … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Science, Sports, Technology, United Kingdom
Tagged Alcatraz duathlon, Bosphorus Cross-Continental Swim, Bristol Medical School, Chrissie Thirlwell, endurance sports, English Channel, fundraising, health and wellbeing, Kirsty Widdowson, leadership, Marfan Trust, medical oncologist, open-water swimming, Strait of Gibraltar, University of Bristol
(IN BRIEF) A study by the University of Warwick and Bielefeld University has tracked more than two hundred young adults over four weeks, collecting 28,000 mood reports through daily smartphone prompts. The research, published in Nature Scientific Reports, shows that … Read the full press release
Posted in Business, Education, Financial, Food & Beverage, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged adenosine receptors, Anu Realo, anxiety, Bielefeld University, caffeine, coffee, depression, dopamine, Justin Hachenberger, mental health, mood, Sakari Lemola, Scientific Reports, sleep problems, tea, University of Warwick, Young Adults
(IN BRIEF) Deka Immobilien has sold the Kalasatama Health Centre in Helsinki for around EUR 100 million to VVT, which acquired it for its VVT Property Fund II KY. Part of the WestInvest ImmoValue portfolio, the 19,800 sqm coastal property … Read the full press release
Posted in Business, Financial, Finland, Germany, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, News, Real Estate, Technology
Tagged City of Helsinki tenant, coastal property Helsinki, Deka Immobilien, EUR 100 million property sale, Finnish commercial property, healthcare property transaction, Helsinki real estate, institutional investment, Kalasatama Health Centre, partnership, real estate asset management, VVT, WestInvest ImmoValue
(IN BRIEF) Montagu and Astorg have welcomed LGT Capital Partners as a new minority shareholder in Nemera, a global leader in drug delivery devices. Montagu and Astorg will remain majority shareholders while partnering with LGT CP to drive Nemera’s next … Read the full press release
Posted in Business, Germany, Healthcare, Investment, News, Pharma & Biotech, United Kingdom
Tagged Andreas Hellmann, Astorg, auto-injectors, biotech solutions, drug delivery devices, Global Expansion, Héloïse Pujolle, inhalers, innovation in healthcare, LGT Capital Partners, manufacturing capacity, Montagu, Nemera, Nicolas Marien, pharmaceutical manufacturing, private equity healthcare investments, proprietary product portfolio
(IN BRIEF) EQT has launched a USD 320 million tender offer through its BPEA EQT Mid-Market Growth Partnership to acquire and privatize CareNet, a leading Japanese digital healthcare platform listed on the Tokyo Stock Exchange. Offering JPY 1,130 per share, … Read the full press release
Posted in Business, Healthcare, Industrial, Investment, Sweden, Technology
Tagged 130 per share, Asia Pacific investment, BPEA EQT Mid-Market Growth Partnership, CareNet, Compass, digital healthcare, EQT, Healthcare Innovation, HRBrain, Indium, Japan healthcare technology, JPY 1, medical education platform, pharmaceutical marketing, Privatization, Takanobu Hara, tender offer, Teruyuki Asaoka, Tokyo Stock Exchange, WSO2
(IN BRIEF) A University of Bristol-led study, published in Nature Food, has shown that reorganising the order of meals on a weekly set menu can cut diners’ carbon footprint by around one-third and reduce saturated fat intake, without altering recipes … Read the full press release
Posted in Business, Education, Environment, Financial, Food & Beverage, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged Alex Sim, Annika Flynn, behavioural insights, carbon footprint reduction, catering innovation, climate change, Jeffrey Brunstrom, menu design, Nature Food, NIHR Bristol Biomedical Research Centre, plant-based meals, public health, Richard Martin, saturated fat reduction, SNEAK project, sustainability, sustainable food choices, Taro Takahashi, UKRI, University of Bristol
(IN BRIEF) The University of Bristol will host a free animal careers advice drop-in session on Wednesday 13 August, from 2 to 4 pm at its Hartcliffe Micro-campus, inviting animal lovers in Withywood, Hartcliffe, and nearby areas to explore career … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Science, Technology, United Kingdom
Tagged animal careers, animal industry training, Animal Welfare, Bristol A.R.C., Bristol Animal Rescue Centre, Bristol Paws Project, Bristol Veterinary School, career change opportunities, community event, free drop-in session, Hartcliffe, Hartcliffe Micro-campus, interactive activities, Langford Vets, partnership, pet care advice, Sheena Warman, University of Bristol, veterinary careers, veterinary education, Withywood
(IN BRIEF) Novartis has reported landmark Phase III results showing that ianalumab significantly reduced disease activity in patients with Sjögren’s disease, meeting primary endpoints in both the NEPTUNUS-1 and NEPTUNUS-2 trials. The treatment, which combines B-cell depletion and BAFF-R inhibition, … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged autoimmune disease, B cell depletion, BAFF-R inhibition, biopharmaceuticals, clinical trial results, ESSDAI, Fast Track Designation, ianalumab, immunology research, MorphoSys AG, NEPTUNUS-1, NEPTUNUS-2, Novartis, Shreeram Aradhye, Sjögren’s disease, systemic autoimmune disorder, targeted therapy, US FDA, VAY736
IN BRIEF) SCHOTT Pharma has introduced the SCHOTT TOPPAC® cartridge, the first ready-to-use polymer cartridge to meet ISO dimensions, offering exceptional dimensional precision and broad device compatibility for injection systems such as pens. Made from COC and designed for sensitive … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged Andreas Reisse, biologics delivery, COC, CPHI Frankfurt, cross-linked siliconization layer, cyclic olefin copolymer, drug containment solutions, drug stability, glass cartridge portfolio, injection devices, ISO-compliant cartridge, overfill geometry, patient-friendly administration, PDA Universe of Pre-Filled Syringes, pen systems, polymer cartridge, prefillable polymer syringes, ready-to-use cartridge, SCHOTT Pharma, SCHOTT TOPPAC cartridge, St. Gallen manufacturing
(IN BRIEF) Amolf researcher Megan Farrell has received the Off Road grant from ZonMW to study how the immune system’s inhibitory receptors act as brakes to prevent autoimmune responses. Using cutting-edge microscopy, she will track these receptors in real time … Read the full press release
Posted in Awards, Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, Netherlands, News, Science, Technology
Tagged AMOLF, autoimmune diseases, Awards, cellular signaling, immune system, immunology research, inflammatory diseases, inhibitory receptors, Kristina Ganzinger, leadership, Megan Farrell, microscopy, Molecular Biology, nanoscale research, Off Road grant, Physics of Cellular Interaction Group, ZonMw
(IN BRIEF) A large-scale study of more than 36,000 people with high blood pressure has shown that walking more steps daily, even below 10,000, and increasing walking pace can significantly reduce the risk of heart and vascular problems. Each extra … Read the full press release
Posted in Business, France, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology
Tagged accelerometer study, cardiovascular disease, daily steps, Emmanuel Stamatakis, European Journal of Preventive Cardiology, European Society of Cardiology, heart disease, heart failure, High blood pressure, hypertension, MACE, Mackenzie Wearables Research Hub, myocardial infarction, physical activity, stroke, UK Biobank, University of Sydney, walking pace
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?